Maintaining infliximab induced clinical remission with azathioprine and 5-aminosalicylates in acute severe steroid-refractory ulcerative colitis has lower cost and high efficacy (MIRACLE): a multicenter study

Background/Aims Infliximab (IFX) has been used to induce and maintain remission in patients with severe steroid-refractory ulcerative colitis (UC). Long-term use of biologics in developing countries is limited by high cost and frequent side effects. An optimal maintenance strategy in these patients...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Ramit Mahajan, Arshdeep Singh, Saurabh Kedia, Kirandeep Kaur, Vandana Midha, Pabitra Sahu, Varun Mehta, Dharmatma Singh, Namita Bansal, Khushdeep Dharni, Sandeep Kaushal, Vineet Ahuja, Ajit Sood
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Korean Association for the Study of Intestinal Diseases 2022-01-01
Edice:	Intestinal Research
Témata:	colitis, ulcerative maintenance infliximab azathioprine mesalamine
On-line přístup:	http://irjournal.org/upload/pdf/ir-2020-00100.pdf
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!